Details of the Drug

General Information of Drug (ID: DMSTZO5)

Drug Name

Tradipitant

Synonyms

Tradipitant; 622370-35-8; LY-686017; VLY-686; UNII-NY0COC51FI; LY686017; NY0COC51FI; Tradipitant [USAN:INN]; Tradipitant(VLY-686); SCHEMBL2898629; GTPL9278; CHEMBL3544984; CAVRKWRKTNINFF-UHFFFAOYSA-N; BCP30446; ZINC43194077; DB12580; SB18893; CS-8056; HY-16732; DA-31788; AS-35293; FT-0703806; Tradipitant

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C28H16ClF6N5O
Canonical SMILES: C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl
InChI: 1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2
InChIKey: CAVRKWRKTNINFF-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 9916461
CAS Number: 622370-35-8
TTD ID: D08GOD

References

1	ClinicalTrials.gov (NCT04326426) ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection. U.S. National Institutes of Health.